Financings
ChanRx Corp. raised $5.5 million in a Series A round for its atrial fibrillation drug.
Coronado Biosciences Inc.'s stock debuted on the Over The Counter Bulletin Board at $11 after taking a Form 10 path to get public.
Portola Pharmaceuticals Inc. raised $89 million in a Series D financing.
Deals
Excaliard Pharmaceuticals Inc. is being acquired by Pfizer Inc. (no terms).
Gilead Sciences Inc. announced plans to acquire Pharmasset Inc. for $11 billion.
. . . And More
EUSA Pharma Inc. got FDA approval of acute lymphoblastic leukemia drug Erwinaze.
Regeneron Pharmaceuticals Inc.'s Eylea (aflibercept) gained FDA approval for wet AMD.
Roche AG/Genentech Inc.'s FDA approval of Avastin (bevacizumab) for breast cancer was revoked.